Publications by authors named "Jennifer Wellman"

Claim this Profile
M
Medicaid coverage practices for approved gene and cell therapies: Existing barriers and proposed policy solutions.
Jeremy Allen, Diane Berry, Francesca Cook, Ashley Hume, Rayne Rouce, Jennifer Wellman

Mol Ther Methods Clin Dev· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the state of Medicaid coverage for gene and cell therapies.
Diane Berry, Jennifer Wellman, Jeremy Allen, Christina Mayer

Mol Ther· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Medicine for Hearing Loss: OTOF as Exemplar.
Ann E Hickox, Michelle D Valero, James T McLaughlin, Gregory S Robinson, Jennifer A Wellman

J Am Acad Audiol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Follow-Up of the First in Human Intravascular Delivery of AAV for Gene Transfer: AAV2-hFIX16 for Severe Hemophilia B.
Lindsey A George, Margaret V Ragni, John E J Rasko, Leslie J Raffini, Benjamin J Samelson-Jones, Jennifer A Wellman

Mol Ther· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy: Results of Phase 1 and 3 Trials.
Albert M Maguire, Stephen Russell, Jennifer A Wellman, Daniel C Chung, Zi-Fan Yu

Ophthalmology· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Natural History of Inherited Retinal Dystrophy Due to Biallelic Mutations in the RPE65 Gene.
Daniel C Chung, Mette Bertelsen, Birgit Lorenz, Mark E Pennesi, Bart P Leroy, Jennifer A Wellman

Am J Ophthalmol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel mobility test to assess functional vision in patients with inherited retinal dystrophies.
Daniel C Chung, Sarah McCague, Zi-Fan Yu, Satha Thill, Julie DiStefano-Pappas, Jennifer Wellman

Clin Exp Ophthalmol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial.
Stephen Russell, Jean Bennett, Jennifer A Wellman, Daniel C Chung, Zi-Fan Yu

Lancet· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial.
Jean Bennett, Jennifer Wellman, Kathleen A Marshall, Sarah McCague, Manzar Ashtari

Lancet· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-year follow-up after unilateral subretinal delivery of adeno-associated virus in patients with Leber congenital Amaurosis type 2.
Francesco Testa, Albert M Maguire, Settimio Rossi, Eric A Pierce, Paolo Melillo, Jennifer Wellman

Ophthalmology· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AAV2 gene therapy readministration in three adults with congenital blindness.
Jean Bennett, Manzar Ashtari, Jennifer Wellman, Kathleen A Marshall, Laura L Cyckowski

Sci Transl Med· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Manufacturing and regulatory strategies for clinical AAV2-hRPE65.
J Fraser Wright, Jennifer Wellman, Katherine A High

Curr Gene Ther· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel caprine adeno-associated virus (AAV) capsid (AAV-Go.1) is closely related to the primate AAV-5 and has unique tropism and neutralization properties.
Alejandra E Arbetman, Michael Lochrie, Shangzhen Zhou, Jennifer Wellman, Ciaran Scallan

J Virol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis